Select Page
Responsive Centered YouTube Video
Discussion on suppressed information regarding IgG4 and COVID-19 implications.
  • Dr. McMillan emphasizes the importance of understanding autoimmunity in the context of the pandemic. 0:03

  • A presentation on the potential consequences of falling vax antibodies was blocked from discussion. 1:28

  • The concept of IgG4 and its implications are being suppressed by the scientific community. 2:40

Concerns raised about potential implications of increased IgG4 levels post mRNA vaccination.
  • Increased IgG4 levels after mRNA vaccination may have significant implications. 2:56

  • IgG4 levels can increase almost 4,000 times post mRNA vaccination. 3:29

  • Vaccination with mRNA leads to a significant increase in IGG percentage. 3:38

  • Severe COVID-19 is characterized by issues in the bloodstream, not just the lungs. 5:13

  • Concerns about spike protein causing damage similar to the virus due to ACE2 binding. 5:39

Discussion on potential autoimmune response triggered by circulating Spike protein and free A2 binding in severe covid-19 cases.
  • Circulating Spike protein binding to A2 may trigger autoimmune response in severe covid-19 cases. 5:48

  • Elevated serum A2 levels linked to severe covid-19, especially in older individuals with comorbidities. 6:39

  • Free floating A2 can potentially bind to Spike protein, leading to immune system targeting both. 7:28

  • Autoantibodies to A2 observed in patients with severe covid-19, indicating autoimmune response. 7:43

  • Theoretical possibility of free floating Spike protein binding to A2 and becoming a target for the immune system. 8:08

  • IgG4 antibodies may play a role in dampening immune response to antigens, similar to bee venom tolerance. 8:26

Discussion on implications of declining IgG4 levels in relation to severe COVID-19 and vaccination.
  • Elevated IgG4 levels may protect against cytokine storms and autoimmune responses. 8:54

  • Decline in IgG4 levels could lead to severe COVID-19 post-vaccination. 9:32

  • Challenges in managing individuals with elevated IgG4 levels and potential risks. 10:12

  • Nuanced approach needed for addressing severe COVID-19 in boosted individuals. 10:22

  • Lack of clarity on identifying individuals who may benefit from interventions. 10:46

  • Political and scientific challenges in discussing and addressing these issues openly. 11:04

  • Scientific community faces obstacles in raising difficult questions and addressing problems. 11:13

Implications of waning IgG4 protection and the need for alternative solutions in the pandemic.
  • Waning IgG4 may lead to more severe disease in boosted individuals. 11:55

  • Lack of alternative options for boosting immunity is concerning. 12:03

  • Acknowledgment of the issue and finding solutions are crucial. 12:27

  • Importance of remaining nuanced, objective, and scientific in approach. 13:03